MEDBOX | Toolbox Booster Doses

TOOLBOX

Advanced search

Create your MEDBOX

TOOLBOX

Advanced search

Create your MEDBOX

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

13 records

	Good practice statement on the use of variant-containing COVID-19 vaccines World Health Organization WHO (2022) C_WHO View PDF(36) Download (14) Add to my MEDBOX Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-19 policy advice to WHO member states and in particular the advice on how to reach the COVID-19 vaccination targets.� Tags: vaccine, omicron, COVID-19, mRNA, variants, Source: https://apps.who.int/iris/rest/bitstream
	Good practice statement on the use of second booster doses for COVID 19 vaccines World Health Organization WHO (2022) C_WHO View PDF(19) Download (12) Add to my MEDBOX 18 August 2022 Tags: booster, COVID-19, second booster, Vaccination, Source: https://apps.who.int/iris/bitstream/hand
	COVID-19 boosters and building trust among UK minority ethnic communities The Lancet (2022) CC Open external link (331) Add to my MEDBOX Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who have had three COVID-19 vaccinations in England in March, 2022, was lowest among Black Caribbean (38%), Black African (45%), and Pakistani (45%) ethnic groups. These disparities are likely to be attributed to the intersection of key social determinants, including socioeconomic factors such as deprivation, overcrowding, and working patterns and conditions, alongside discrimination and structural violence in the health-care system and society Tags: COVID-19, minority groups, united kingdom, UK, booster, Source: https://www.thelancet.com/action/showPdf
	Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2022) C1 View PDF(96) Download (67) Add to my MEDBOX Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfempfehlung ist es, Personen, die eine COVID-19-Impfung mit einem der nicht in der EU zugelassenen Ganzvirusimpfstoffen (CoronaVac, Covilo und Covaxin) oder dem Vektor-basierten Impfstoff Sputnik V erhalten haben, mit einem Impfschutz auszustatten, der vergleichbar mit dem einer Grundimmunisierung plus Auffrischimpfung mit einem mRNA-Impfstoff ist Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents, booster, Source: https://www.rki.de/DE/Content/Infekt/Epi
	Guidance on administration of COVID-19 vaccine boosters in Africa African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC View PDF(27) Download (19) Add to my MEDBOX 17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize social disruption and economic consequences of COVID-19, curtail the emergence of new SARS-CoV-2 variants of concern (VOCs) and ultimately control the pandemic Tags: booster, vaccine, COVID-19, Africa, strategy, Source: https://africacdc.org/download/guidance-
	Interim recommendations for heterologous COVID-19 vaccine schedules World Health Organization WHO (2021) C_WHO View PDF(24) Download (19) Add to my MEDBOX Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine) Tags: booster, vaccine, COVID-19, heterologous, mixed doses, Source: https://apps.who.int/iris/rest/bitstream
	Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons World Health Organization WHO (2021) C_WHO View PDF(19) Download (16) Add to my MEDBOX Interim guidance, 26 October 2021 This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021. SAGE said moderately and severely immunocompromised persons should be offered an additional dose of all WHO approved vaccines “since these individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe COVID-19 disease.” People aged 60 and older who received the Sinovac and Sinopharm vaccines should get a third dose too, the experts added, though use of other vaccines may also be considered depending on supply and access. “When implementing this recommendation, countries should initially aim at maximizing 2-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups”, they said. SAGE has also reviewed a vaccine developed by Indian company Bharat Biotech and will issue a policy recommendation after WHO greenlights it for emergency use Tags: booster, Vaccination, immunocompromised, vulnerable groups, COVID-19, Source: https://www.who.int/publications/i/item/
	Update 66 – COVID-19 vaccine booster doses World Health Organization WHO (2021) CC View PDF(47) Download (28) Add to my MEDBOX September 2021 Tags: booster, vaccine, COVID-19, Source: https://cdn.who.int/media/docs/default-s
	Interim statement on COVID-19 vaccine booster doses World Health Organization WHO (2021) C_WHO Open external link (321) Add to my MEDBOX 7 August 2021 Tags: vaccine supply, COVID-19, Access, booster, equitable, accèss, fair allocation, global, Source: https://www.who.int/news/item/10-08-2021
	Dosis adicional del esquema primario de vacunación contra COVID-19: Campaña Nacional de Vacunación contra la COVID-19 Dirección de Control de Enfermedades Inmunoprevenibles Ministerio de Salud Argentina (2021) CC View PDF(31) Download (13) Add to my MEDBOX Additional dose of the primary vaccination against COVID-19: Technical Guidelines Tags: COVID-19, vaccination, Booster, guidelines, Argentina, Source: https://bancos.salud.gob.ar/recurso/dosi

13 records

13 records